Pancreatic cancer is one of the most aggres sive malignant
tumors with dismal
prognosis.The 2017 annualmeeting of the American Society of
Clinical Oncology (ASCO)brings together thousands of oncology professionals from around the world to discuss
state-of-the-
art treatment modalities,new
therapies,and ongoing controversies in the field.In this
paper,authors selected and reviewed
pancreatic cancer research from 2017 annual meeting of the ASCO,especially the latest
research progress in genetic
diagnosis,
chemotherapy,
immunotherapy,targeted
therapy and
neoadjuvant treatments.